ARMPArmata Pharmaceuticals, Inc.

NYSE armatapharma.com


$ 2.82 $ -0.10 (-3.5 %)    

Wednesday, 08-May-2024 15:59:40 EDT
QQQ $ 440.56 $ 0.10 (0.02 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.04 $ 0.00 (0 %)
GLD $ 214.13 $ -0.57 (-0.27 %)
$ 2.76
$ 2.79
$ 0.00 x 0
$ 0.00 x 0
$ 2.79 - $ 2.82
$ 1.07 - $ 5.26
6,076
na
99.7M
$ 0.71
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-21-2024 12-31-2023 10-K
3 08-14-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-16-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-12-2022 03-31-2022 10-Q
9 03-17-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-12-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-18-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-13-2020 06-30-2020 10-Q
16 05-14-2020 03-31-2020 10-Q
17 03-19-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-06-2019 03-31-2019 10-Q
21 03-25-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-09-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 03-27-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-15-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-16-2015 09-30-2015 10-Q
35 08-13-2015 06-30-2015 10-Q
36 05-15-2015 03-31-2015 10-Q
37 04-15-2015 12-31-2014 10-K
38 11-14-2014 09-30-2014 10-Q
39 09-12-2014 06-30-2014 10-Q
40 05-20-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

 armata-pharmaceuticals-q1-eps-069-misses-031-estimate-sales-96600k-miss-110m-estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate o...

 hc-wainwright--co-maintains-buy-on-armata-pharmaceuticals-maintains-7-price-target

HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 pr...

 armata-pharmaceuticals-q4-eps-055-misses-035-estimate-sales-153m-beat-86000k-estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate o...

Core News & Articles

The gross proceeds to be received by the Company at closing are $35 million before deducting transaction-related expenses. Proc...

 armata-pharmaceuticals-q3-eps-086-misses-031-estimate-sales-123m-beat-95000k-estimate

Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate o...

 hc-wainwright--co-reiterates-buy-on-armata-pharmaceuticals-maintains-7-price-target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 p...

 why-universal-health-services-shares-are-trading-lower-by-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Gainers Silicon Motion Technology Corporation (NASDAQ: SIMO) shares climbed 78.9% to $93.40 following a report suggesting C...

 why-ryanair-holdings-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor i...

 dow-surges-150-points-dominos-pizza-earnings-top-expectations

U.S. stocks traded higher this morning, with the Dow Jones gaining over 150 points on Monday. Following the market opening Mon...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION